It is conceivable that transfected NT-3 cells develop only a partial ALT phenotype accompanied by a lower responsiveness to Berzozertib compared to DAXX mutated tumor cells, since siRNA-mediated DAXX knockdown resulted in only a partial reduction in DAXX expression. The gene discussed is DAXX; the disease is neoplasm.